Fadi Haddad, MD @FadiHaddad_MD Twitter profile

Last Seen Profiles

@yutoplant

@FreemanEle10562

@Strickland64635

@kaiisGod15

@EllenBoucher18

@Fkarla

@miggysburner

@TriciaRami59494

@KC_Ragni

@JayMulla21

@Yuu___sa0

@Boss_StudioRBLX

@FremFrem580158

@adelaide62777

@DPS_Goat

@miperrico

@1sun

@Alanqri_fahad

@AltoMediefuck

@andreiamng

@ElmiraNish26791

@SandraHoga75709

@josedlujan

@HagerLori43128

@GinaMullin96044

@PustoiSimon

@AdrianJ16177076

@GraceFrimpong18

@Mich72051487

@A7xFVOficial

@Niewolnicy99988

@man_undi

@EulaRobert25878

@KyliSamone

@JacquelynM47886

@RobEdwa05769476

Fadi Haddad, MD

@FadiHaddad_MD

1 year

Excited 🔥 to start my new role as Assistant Professor in the #Leukemia Department at @MDAndersonNews & working with experts, colleagues & family! #AML #ALL #CML #CLL #MDS #MPN Looking forward for an amazing scientific & clinical journey to #endcancer 😊

76

9

497

Fadi Haddad, MD

@FadiHaddad_MD

1 year

☀️ Sunny Sunday over #Houston Rounding with @NassifElise because #cancer does not take a break, so do us👊 working with my fiancée to #endcancer @MDAndersonNews #leukemia #sarcoma #leusm #powercouple

5

7

134

Fadi Haddad, MD

@FadiHaddad_MD

3 years

Happy to present our Abstract Achievement Award winning abstract at @ASH_hematology #ASH21 from @MDAndersonNews #leusm Reshaping the treatment of Acute Lymphoblastic Leukemia. Thanks to my great mentors @NicholasShortMD Elias Jabbour @DrHKantarjian

21

5

122

Fadi Haddad, MD

@FadiHaddad_MD

1 year

Pr. Elias Jabbour from @MDAndersonNews awarded The Ben Qurrah Award for his achievements in the treatment of leukemia that impact the lives of thousands of patients around the world 🌍 @DrHKantarjian #NAAMA #leusm

3

8

121

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Because #Cancers & #Leukemia don't know weekends or breaks, we also don't ✋Donate #Blood 🩸to help our cancer #patients @MDAndersonNews #BloodDonation #endcancer #MedTwitter #leusm

4

6

111

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Unforgettable memories from our #graduation dinner 🧑‍🎓with our #Leukemia family @MDAndersonNews Very happy to be part of this amazing team of brilliant💡 & humble physicians/scientists💥 Humbled to receive the Fellow of the Year #award & looking forward to the new #journey ahead🙏

19

4

107

Fadi Haddad, MD

@FadiHaddad_MD

1 year

11/30/22‼️Memorable first day on the floors with @garciamanero 😍 Inspiring mentor & amazing Program Director! Looking forward for more science & fun times 😇 #leusm

1

2

107

Fadi Haddad, MD

@FadiHaddad_MD

1 year

Christmas Day🎄 rounds on #Leukemia floors with such an amazing team 🎅 working together to #endcancer @MDAndersonNews

2

100

Fadi Haddad, MD

@FadiHaddad_MD

6 months

#Thanksgiving rounds with my wife @NassifElise 🌻 🙏 Wishing you all a Happy Thanksgiving 👊 Always 💯 ready to bring hope to our patients 💫 Grateful for all the team (nurses, APPs, fellows, PharmD, personnel...) who are working hard to #endcancer #leusm #sarcoma #powercouple

4

1

96

Fadi Haddad, MD

@FadiHaddad_MD

7 months

Honored to receive the Best Overall Abstract #Award at the 15th International Congress on #MPN 🏅 discussing long-term outcome in #CML in #NYC #Brooklyn #leusm @MDAndersonNews @DrHKantarjian

Naveen Pemmaraju, MD

@doctorpemm

7 months

Congratulations to Dr Fadi Haddad . @FadiHaddad_MD 👉Winner of Best Overall Abstract Award 🥇 at the 15th International Congress on MPNs #NYC !!!!! #MPNSM #leusm @MDAndersonNews #endcancer

3

8

66

14

4

97

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Honored to have been selected for @ConquerCancerFd Merit Award with super🌟 #Leukemia #fellows @jayastuMD & Faustine Ong💥& our #sarcoma #Immunology rising✨ @NassifElise VERY grateful for our mentors at @MDAndersonNews #MedTwitter #leusm @ASCO #ASCO22 #oncology #hemsm

9

4

89

Fadi Haddad, MD

@FadiHaddad_MD

5 months

Honored to present at #ASH2023 dasatinib+VEN in FL #CML 💊 Dasatinib C1-C3 ➡️ Dasatinib+VEN x3 yrs ➡️ dasatinib only 🔹After 12 mo of combo: MMR 86%, MR4 53% 🔸Higher risk of neutropenia ⁉️ Similar outcomes compared to dasatinib alone ➡️ Longer F/U needed #leusm @MDAndersonNews

5

7

86

Fadi Haddad, MD

@FadiHaddad_MD

11 months

Walking away from chemotherapy in Philadelphia+ #ALL presented by Pr. Elias Jabbour from @MDAndersonNews ➡️ Proposed algorithm based on MRD evaluation ➡️ CAR-T cells +/- transplant for patients with persistent MRD #leusm

6

15

86

Fadi Haddad, MD

@FadiHaddad_MD

2 years

📣 Just out in @jamaonc our comprehensive review on Ph-positive acute lymphoblastic leukemia #ALL ➡️ all you need to know about low- & high-intensity therapies, & very promising chemo-free regimens🤞 @DrHKantarjian @NicholasShortMD #leusm #Leukemia

Treatment of Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

This Review reports current evidence for frontline therapies of Philadelphia chromosome–positive acute lymphoblastic leukemia, the major principles that guide therapy, and the progress with chemoth...

jamanetwork.com

2

19

77

Fadi Haddad, MD

@FadiHaddad_MD

1 year

#NewProfilePic

0

76

Fadi Haddad, MD

@FadiHaddad_MD

6 months

🚨 Thrilled to see my colleague & brother @jayastuMD joining the #Leukemia Department 💥 at @MDAndersonNews as Assistant Professor 🏅 Looking forward to working together to #endcancer #leusm

6

3

72

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Exciting clinic day 💥 with this amazing #team 🌟working constantly to #endcancer Mentors & Mentees in the frame 😎 #leukemia #leusm #MedTwitter #Motivation #energy @MDAndersonNews

3

5

73

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Listening 👂 to the best #lebanese 🇱🇧 music 🎶 while writing articles 📝 Feeling nostalgic 😶 #nostalgia #فيروز #Lebanon #Science #leusm #MedTwitter

6

2

70

Fadi Haddad, MD

@FadiHaddad_MD

2 years

😊 Happy #fellows travelling ✈️ to #ASCO22 with the best💥 #PD in town @garciamanero 🥇 to present our work & #research from @MDAndersonNews & connect/learn @ASCO @jayastuMD #endcaner #Leukemia #leusm #MedTwitter

2

5

69

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Early rounds on #Thanksgiving day. Whising you all blessed holidays & health for our patients 🙏🏻 @MDAndersonNews #Blessings #leusm

0

68

Fadi Haddad, MD

@FadiHaddad_MD

9 months

Congratulations Pr @DrHKantarjian for the Emil J Freireich Distinguished Pioneer Award at @SocietyofHemOnc #SOHO2023 Great overview of the achievements of Pr Freireich & the development of #ALL therapies & future directions. #leusm #leukemia #cure @MDAndersonNews @Lisa_Palacios

2

11

65

Fadi Haddad, MD

@FadiHaddad_MD

6 months

🏅Beyond proud of my wife @NassifElise from @MDAndersonNews defending her #PhD thesis in #Lyon 🇫🇷 on B-cells/TLS/ICB in #sarcoma 🚨High quality work, data & presentation 💡New ideas & discoveries ➡️ Keep 👀 on the amazing work she's doing to bring hope to patients with #cancer 🙏

5

6

63

Fadi Haddad, MD

@FadiHaddad_MD

9 months

Congratulations @doctorpemm from @MDAndersonNews awarded the best poster for the addition of #Navitoclax to #Ruxolitinib in #myelofibrosis patients at #SOHO2023 🏅🎊 #leusm #BPDCN #MPN

3

7

61

Fadi Haddad, MD

@FadiHaddad_MD

9 months

⚠️⚠️ You are all invited to donate blood 🩸 at #SOHO2023 & help patients with cancer at @MDAndersonNews 🙏 Please stop by our blood drive ➡️➡️ ROOM 310A #blood #DonateBloodSaveLives #leusm #leukemia

0

8

60

Fadi Haddad, MD

@FadiHaddad_MD

3 years

The most precious time of my day were the 20 minutes I spent explaining the treatment plan to an anxious patient! Totally relieved... To my friends colleagues: your time is the best medicine you can ever give🙌🏻 #medtwitter #leusm

2

3

57

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Just out 📢 in @AjHematology our study on treatment-free remission (TFR) in #CML pts after stopping therapy. Helpful details in thread ⬇️⬇️⬇️ @MDAndersonNews @DrHKantarjian @GCC_Cortes @GhayasIssa @doctorpemm @garciamanero @TapKadia @NitinJainMD

Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of...

The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.

onlinelibrary.wiley.com

1

14

57

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Saturday #round is easier when the great @TapKadia 🏅💥 has your back 😎 Better be inside in this freezing weather ❄️ #coldwave #leusm #MedTwitter #HoustonTX #endcancer @MDAndersonNews

2

56

Fadi Haddad, MD

@FadiHaddad_MD

1 year

📢 Just out for #ASH22 Evidence-based ASH mini-review: What is the optimal TKI in Ph-positive ALL? @NicholasShortMD @ASH_hematology #leukemia #cure #endcancer #ASH #leusm #ALL ⬇️⬇️⬇️

2

10

52

Fadi Haddad, MD

@FadiHaddad_MD

7 months

❄️ When #Hosuton hits you with cold weather over night ☃️ but you want to continue your #mission 🛤️to #endcancer 👊 @MDAndersonNews #tea #leusm #research #leukemia

3

4

52

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Thought of the day. Happy weekend my friends 🙌🏻✨ #MotivationalQuotes #Reading #investing #improvinglives #BetterDays

2

13

48

Fadi Haddad, MD

@FadiHaddad_MD

1 year

The most charming & #magical time of the year💫 What's better than starting your morning #rounds with this #Christmas tree 🎄 at @MDAndersonNews A lot of positive energy for us to give for our patients during this blessed period 🙏🙏 #endcancer

0

3

50

Fadi Haddad, MD

@FadiHaddad_MD

2 years

📢Happy to share my paper #52 during Residency/Fellowship☺️& looking forward for more impactful research📑Our #expert opinion on #Ponatinib for intolerant or resistant #CML @MusaYilmazMD @GhayasIssa @MDAndersonNews #MedTwitter #leusm

4

48

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Chemotherapy-free regimens are the future/"present" of Ph-positive acute lymphoblastic leukemia #leusm #leukemia #cure #Cancer #endcancer @MDAndersonNews

Hagop Kantarjian,MD

@DrHKantarjian

2 years

Ph-positive #ALL therapy: Chemo-Free at Last? CMR rate of 86% and 2-year OS rate of 93% Published now in @JAMAOnc review from Elias Jabbour, MD, @FadiHaddad_MD , and @NicholasShortMD of @MDAndersonNews #Leukemia #leusm

3

36

161

1

6

48

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Thank you #ASCO22 for this interesting meeting 🌟 Going back ✈️ to #Houston with positive energy 💥 #PowerCouple with @NassifElise ✌️ Fruitful days with @ConquerCancerFd awards, poster and oral presentations🥇 Looking forward for future meetings🎊

0

3

48

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Thank you @MDAndersonNews for sharing the work from our #leukemia group at #ASCO22 on treatment discontinuation in patients with CML #leusm All you need to know in this video⬇️⬇️⬇️ @DrHKantarjian @GhayasIssa @GCC_Cortes @doctorpemm @MusaYilmazMD @TapKadia

MD Anderson Cancer Center

@MDAndersonNews

2 years

Which chronic myeloid leukemia patients can achieve treatment-free remission? Dr. Fadi Haddad presented findings that help identify patients that may be able to can discontinue tyrosine kinase inhibitors without harm: #ASCO22 @FadiHaddad_MD #EndCancer

2

7

60

3

2

46

Fadi Haddad, MD

@FadiHaddad_MD

3 years

Promising agents/new options coming for AML/MDS with CD47 blockade! Check our mini-review with the expert & great mentor @Daver_Leukemia @LeukemiaMDA @MDAndersonNews @JIPOEditors #leusm #MedTwitter

Naval Daver, M.D.

@Daver_Leukemia

3 years

Excited to have our mini review on CD47/SiRPa based therapies in AML and MDS out. Agents to look out for in the coming years! Great work @FadyyHaddad . Thank you @JIPOEditors @ANaingMD @HajjarJoud

0

6

21

0

6

43

Fadi Haddad, MD

@FadiHaddad_MD

11 months

Summary on the management of Ph-like #ALL ➡️ TKIs effective in patients with ABL1 or ABL2 fusions, mostly in the first-line setting ➡️ ANTIBODIES (InO, blina) improve outcomes ➡️ Favor transplant in CR1 #leusm @NitinJainMD @jayastuMD @_MDEducation

0

15

43

Fadi Haddad, MD

@FadiHaddad_MD

9 months

Congratulations Pr Elias Jabbour from @MDAndersonNews for the Poster Award at @SocietyofHemOnc 🏅 #SOHO2023 #leusm @Lisa_Palacios

0

5

42

Fadi Haddad, MD

@FadiHaddad_MD

1 year

📣 Just out in @Nature Great work led by @GhayasIssa from @MDAndersonNews establishes the role of menin inhibitors as a novel treatment option for susceptible #leukemia subtypes #leusm #cure #endcancer

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Nature - Revumenib, a potent and selective oral inhibitor of the menin–KMT2A interaction, is associated with a low frequency of treatment-related adverse events and promising clinical...

www.nature.com

2

6

43

Fadi Haddad, MD

@FadiHaddad_MD

2 years

📢 Out in @AjHematology dasatinib 50mg as effective & less toxic than 100 mg in #CML #Leukemia #leusm ⬇️Pleural effusions (5% vs 20%) ⬆️High rates of deep molecular response ⬆️FFS ⬇️Discontinuation ⚠️Caution when using lower dose in high-risk patients

0

10

41

Fadi Haddad, MD

@FadiHaddad_MD

11 months

Congratulations to all our #leukemia #fellows for the graduation. Such wonderful times to be united as a family! 📢 Shout-out to the brilliant @jayastuMD for being selected Clinical Fellow of the Year🏅 @MDAndersonNews @DrHKantarjian @TapKadia @garciamanero #MedTwitter #leusm

Naveen Pemmaraju, MD

@doctorpemm

11 months

🙌 Fantastic occasion celebrating our Leukemia Fellows Graduation yest evening! Congrats to @jayastuMD & our amazing leukemia fellows & we wish them our very best !! 🙏🏾 to our Chair @DrHKantarjian , PD @garciamanero & Associate PD @TapKadia @FadiHaddad_MD @doctorpemm @jayastuMD

6

1

51

2

3

42

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Congratulations @garciamanero , recipient of the Emil J Freireich Distinguished Pioneer Award at #SOHO22 @MDAndersonNews Phenomenal talk on the total approach to MDS #leusm #mdssm #leukemia

0

5

41

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Witnessed history: pt w/ #CML on #imatinib for 20 years stopped therapy 🤞🏻hopefully cured🤞🏻 Treatment-free remission is the 🎯 Higher rates than ever in pts with MR4 or MR4.5 >5y Full details📢 @ #ASH21 @MDAndersonNews @DrHKantarjian @GhayasIssa @doctorpemm @GCC_Cortes #leusm

0

6

40

Fadi Haddad, MD

@FadiHaddad_MD

4 years

Des étudiants de la Faculté de Médecine de #USJ mobilisés pour assurer des soins et des médicaments dans la région de Gemmayzeh/Mar Mkhael sous la coordination de l'Opération 7ème jour @USJLiban

2

9

39

Fadi Haddad, MD

@FadiHaddad_MD

3 years

Looking for a #lebanese medical #student , #hardowrker 🤓, with computer skills 💻 to help with a medical project over the internet 🌐 Message me only if interested❗

3

10

39

Fadi Haddad, MD

@FadiHaddad_MD

1 year

Great #MPN #MDS meeting in Phoenix ➡️ gathering of experts to discuss latest updates, insightful discussions, science, friends, colleagues & fun times😁 #leusm #MDeducation

1

3

40

Fadi Haddad, MD

@FadiHaddad_MD

2 years

📢Just out in @TheLancetHaem Chemotherapy-free regimen of blinatumomab+ponatinib highly effective for ND & R/R Ph+ ALL In ND pts: ✅CMR 86% ✅Transplant in only 1 pt‼️ ✅1-year EFS and OS = 95% @MDAndersonNews @DrHKantarjian @NicholasShortMD @NitinJainMD #leukemia #leusm

The Lancet Haematology

@TheLancetHaem

2 years

NOW OF: In a single-centre, single-arm, ph 2 trial, 33 (87%) of 38 patients with ND and 11 (79%) of 13 with R/R Ph-positive ALL and 2 (33%) of 6 patients with blast-phase CML had a complete molecular response with ponatinib and blinatumomab. #leusm

1

20

55

2

9

37

Fadi Haddad, MD

@FadiHaddad_MD

2 years

🏥One week into the #Pemmaraju #Program #PP of Inpatient #rounds @doctorpemm 🔥 a lot of knowledge🤓and good times😎 shout out 📣 for all amazing #nurses on this #nursesweek2022 #leusm #MedTwitter #BPDCN @MDAndersonNews #endcancer

1

2

35

Fadi Haddad, MD

@FadiHaddad_MD

7 months

🚨 Out in @BloodJournal P2 trial ⬇️ #Inotuzumab safe & effective in B-ALL with ➕ MRD 🔹MRD negativity 69% 🔹2-year RFS 54% 🔹2-year OS 60% Full article ⬇️⬇️ #leusm #oncoalert @MDAndersonNews @DrHKantarjian @NicholasShortMD @NitinJainMD @jayastuMD

0

7

35

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Highlighted in @TheLancetHaem ➡️ Chemotherapy-free regimen of ponatinib+blinatumomab = high remission rates & prolonged survival. In the Frontline setting, no relapses are seen & only 1 patient was transplanted🎖️🏆 @DrHKantarjian @NicholasShortMD @MDAndersonNews #leusm #SOHO22

The Lancet Haematology

@TheLancetHaem

2 years

#SOHO2022 Fadi Haddad presents updates from a ph 2 study of blinatumomab + ponatinib in Ph-positive #ALL . CMR rate was 85% for newly diagnosed and 79% for R/R disease, and ORR was 96% and 92%.

0

21

49

5

7

33

Fadi Haddad, MD

@FadiHaddad_MD

4 years

Because caring for patients is our priority🥇The oncology team at Hôtel-Dieu de France hospital in Beirut 🏥 got mobilized against COVID-19 😷 to ensure the best quality of care for our patients ⚠️

3

32

Fadi Haddad, MD

@FadiHaddad_MD

8 months

🏅Great #CML talk as always by @GCC_Cortes at the #HemeSummit23 🔹Don't push for deeper & earlier responses if not needed ➡️ can lead to more toxicities‼️ 🔹Adjusting TKI doses 🔹Listen to the patient needs 📢 🔹CML not done yet, work still needs to be done... #leusm #mpnsm

0

5

32

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Gut microbiome->⬆️ response to #Immunotherapy -> rationale for future studies💥Watch for this Oral presentation @ @ASCO @ASCOPost #ASCO22 by Superstar 🌟 @NassifElise from exceptional #sarcoma team🏅 @ @MDAndersonNews @emilykeungMD @CrisyRoland @JenWargoMD

2

7

33

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Very interesting reflection this morning with @DrHKantarjian grand rounds💡 @MDAndersonNews More attention should be paid to Bayesian study designs ➡️ can give faster access to clinical data & therefore can benefit more patients + clinicians. #research #science #Leukemia #leusm

0

4

31

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Amazing presentation & discussion🎖️ with @Rfonsi1 on the role on MRD in #MultipleMyeloma . Very promising how the field is evolving with more sensitive testing & more potent therapies!! 🔥 #mmsm

2

9

31

Fadi Haddad, MD

@FadiHaddad_MD

11 months

"True research begins AFTER #FDA approval of the drug" - @DrHKantarjian highlighted by @Daver_Leukemia A lot of work to be done after drugs are approved to optimize dosing & reduce the risk of AEs while maintaining efficacy, such as with #venetoclax #leusm

0

6

31

Fadi Haddad, MD

@FadiHaddad_MD

1 year

#CML & #BariatricSurgery 💊 Design💡 * Pts screened: 652 * Matched CML pts: 22 w/ & 44 w/o Bariatric Surgery Results🧾 * 3-mo BCR::ABL1 <10% lower in Bariatric Surgery group compared w/ control (68% vs 91%; P=.05) * Longer time to CCyR, MMR Cont'd ⬇️⬇️

Association between bariatric surgery and outcomes in chronic myeloid leukemia

Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.

acsjournals.onlinelibrary.wiley.com

4

5

31

Fadi Haddad, MD

@FadiHaddad_MD

11 months

Comprehensive talk by @TapKadia from @MDAndersonNews discussing maintenance strategies in #AML ➡️ Personnalized approach based on the presence or absence of mutations ➡️ MRD impacts the response to FLT3-based maintenance ➡️ All-oral strategies evolving #leusm @_MDEducation

0

6

30

Fadi Haddad, MD

@FadiHaddad_MD

1 year

Very nice & interactive discussion of best #MPN abstracts (disease modification, CALR directed therapies, etc...) from @ASH_hematology #TwitterSpace thank you @doctorpemm @NitinJainMD @Anand_88_Patel for these educational meetings!! 😊

2

4

27

Fadi Haddad, MD

@FadiHaddad_MD

2 years

🤦Spending my evening recording poster presentations for #ASH22 ‼️Pandemic is over & @ASH_hematology should revisit the strategy of recording poster presentations when the poster is actually submitted! I am also not sure how many are actually listening to those #recodrings ??!!!

4

0

29

Fadi Haddad, MD

@FadiHaddad_MD

7 months

DDX41 mutations ⬇️⬇️ 🔹Germline pathogenic variants = relatively common (1/429) 🔹 Increased risk of MDS/AML 🔹Progression more common in somatic DDX41 variants 🔸Responsive to #venetoclax as previously published #leusm #leukemia #OncoAlert @BloodJournal

2

10

30

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Rusfertide (PTG-300) a new hepcidin mimetic for the treatment of polycythemia vera. Very exciting results 🔥 presented very nicely by the expert @doctorpemm from @MDAndersonNews 🏆 at #SOHO2022 #mpnsm #leusm #leukemia

1

7

29

Fadi Haddad, MD

@FadiHaddad_MD

8 months

☕Morning discussions with @VivekSubbiah at #HemeSummit23 on #PrecisionMedicine 🎯 to improve the care of patients with #leukemia 🩸 🏅Novel strategies offering #hope to patients with #Cancer & rare malignancies 💻Growing role for AI ‼️ #leusm #cure #Future

1

29

Fadi Haddad, MD

@FadiHaddad_MD

1 year

A lot of exciting data in CAR-T cells for #leukemias & #lymphomas with experts in the field. Great job by @NitinJainMD for the organization! Interesting reflections & discussions that will move the field forward🤞

0

1

29

Fadi Haddad, MD

@FadiHaddad_MD

10 months

#MedTwitter be on the lookout for SUPERSTAR Dr Jayastu Senapati @jayastuMD 🏅who's joining the Leukemia family at @MDAndersonNews Brilliant scientist, dedicated physician, & amazing colleague and friend🏆 #leusm

Nitin Jain

@NitinJainMD

10 months

Super cheers to our super 🌟 Leukemia fellow Dr Senapati @jayastuMD who is completing Leukemia fellowship and will join us as Faculty in the Department of Leukemia 👏👏🎊🎉 @MDAndersonNews Wishing you all the BEST!! WELCOME!! Super proud @DrHKantarjian @garciamanero @TapKadia

47

6

188

1

28

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Ph-positive ALL field moving away from chemotherapy and transplant, with very promising survival rates with blinatumomab and ponatinib! #SOHO22 #MedTwitter #leusm

Ali Atoui, MD

@AliAtoui11

2 years

Great presentation on the updated results of Ponatinib and Blinatumumab in Ph + ALL by @FadiHaddad_MD . CR/CRi 96% in frontline and 92% in R/R. Promising chemo-free regimen. #SOHO22

1

4

45

0

6

28

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Thank you @Larvol for sharing. Twitter & #socialmedia are super important tools for #Medical #education & #Awareness #CME #updates #leukemia #leusm #influencers #medfolia ... Stay tuned👀

LARVOL

@Larvol

2 years

Here's a look at the top 10 influential voices on Twitter from #SOHO22 ! 1. @FadiHaddad_MD 2. @doctorpemm 3. @jayastuMD 4. @DrJCornago 5. @Lymphoma_Doc 6. @garciamanero 7. @nicholasShortMD 8. @JAMouabbi 9. @vishsath 10. @joshuaafein #hematology #SOHO2022

1

3

21

2

3

28

Fadi Haddad, MD

@FadiHaddad_MD

3 years

Menin inhibitors will revolutionize treatment of #leukemia with #MLL rearrangement! The beginning of a new era of curing high-risk #disease #leusm #ALL #AML @MDAndersonNews @LeukemiaMDA

Hagop Kantarjian,MD

@DrHKantarjian

3 years

Now we have menin inhibitors that should improve KMT2A (MLL) #leukemia outcome Outcomes of Acute Lymphoblastic Leukemia with KMT2A (MLL) rearrangement - The MD Anderson Experience @MDAndersonNews via @BloodAdvances | #leusm #ALL

0

28

116

1

6

28

Fadi Haddad, MD

@FadiHaddad_MD

8 months

🚨 IM #programs Full support for @lewisnasr working as post-doc at @MDAndersonNews @NicholasShortMD @DrHKantarjian ✅ Extremely hardworking ✅ Super motivated ✅ Great character ✅ Team player ✅ Highly reliable and trustworthy 💯 Recommended for #TOP programs!! #MedTwitter

Lewis Nasr

@lewisnasr

8 months

Hello #MedTwitter ! I'm Lewis Nasr, @USJLiban alumnus🇱🇧 currently doing research at @MDAndersonNews . I'm thrilled to be applying to #InternalMedicine residency this #Match2024 . Wishing all applicants the best of luck, I look forward to connect!

33

9

141

2

1

26

Fadi Haddad, MD

@FadiHaddad_MD

2 years

👉 Join us at #ASCO22 on June 4 (8:00-11:00 AM) to discuss treatment discontinuation in patients with #CML Check this #ASCODailyNews report ⬇️⬇️⬇️ for an updated analysis on treatment-free remission in #CML #leusm #MedTwitter #ASCO @MDAndersonNews

ASCO

@ASCO

2 years

Duration of deep molecular response associated w/ maintaining treatment-free remission after #TKI discontinuation in patients w/ #CML . @FadiHaddad_MD #ASCO22 #ASCODailyNews #leusm

0

6

20

0

5

27

Fadi Haddad, MD

@FadiHaddad_MD

3 years

"Humans cannot live without hope. Hopelessness is the greatest trauma a person has to suffer" - Emil J. Freireich, MD @MDAndersonNews @LeukemiaMDA

2

23

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Very educational 🤓 inaugural session of @HemeReports & great discussion 🧑‍⚕️with @NitinJainMD @sanamloghavi @doctorpemm @mpdrc @KMirza @Anand_88 @jayastuMD I encourage all fellows & residents interested in #hematology to join future ➡️ meetings #MedTwitter #leusm #education

0

4

26

Fadi Haddad, MD

@FadiHaddad_MD

3 years

Was amazed to see a patient today treated on a phase 1 #trial more than 2 decades ago with an investigational 💊 that became later commercially available! She's CURED...making #Cancer #history #leusm @MDAndersonNews

1

26

Fadi Haddad, MD

@FadiHaddad_MD

4 months

Out in @JCO_ASCO Update dasatinib-Blina in Ph+ALL 👫63 pts 💊Dasatinib then sequential blina 🔹Molecular response 60% 🔹OS 81%, EFS 75% 🔸50% got HSCT 🔸9 relapses (7 T315I; 4 🧠) ➡️Effective & safe but NOT totally chemo-free regimen‼️ #OncoAlert #leusm

Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned coprimary or...

ascopubs.org

1

12

27

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Enjoyed listening to this comprehensive talk by @TapKadia on non-intensive treatment of elderly/unfit patients with AML! A lot of exciting news coming... Stay tuned 📰😎 #leusm #leukemia

1

4

25

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Full #moon 🌕 City #Lights 💡& perfect #Weather over #Houston 🇺🇲 at Miller Outdoor Theater for the Houston #ballet 🎭 ➕ Great company 😊 #culture #Showtime #friend #selfcare #Moments

2

1

24

Fadi Haddad, MD

@FadiHaddad_MD

11 months

@Daver_Leukemia from @MDAndersonNews presenting the data on upfront triplet combinations in #AML ➡️ All-oral therapies evolving ➡️ Higher remission rates compared with sequential single agent therapies ➡️ HMA+VEN backbone with anti-FLT3/IDH/TP53 #leusm @_MDEducation

1

6

23

Fadi Haddad, MD

@FadiHaddad_MD

4 months

🚨Out in @BloodAdvances 💊Ph 1/2 VEN+low-intensity chemo from @MDAndersonNews led by @NicholasShortMD 👫 22 pts w/ #ALL 🔹CR/CRi 57%, MRD neg 45%, 4 SCT 🔹DOR 6.3 mo, OS 7.1 mo, 1y OS 29% 🔸AEs=infection, FN ➡️ Active combo in R/R ALL #leusm @OncoAlert

A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute...

Low-intensity chemotherapy plus venetoclax was safe and active in heavily pretreated relapsed/refractory ALL.The CR/CRi rate of 57% compares favorably with

ashpublications.org

2

6

23

Fadi Haddad, MD

@FadiHaddad_MD

5 months

🚨Very promising results with "dose-dense" miniHCVD+Blina+InO 👫N=21 (ND, MRD+, R/R) 🔹ND ➡️ 100% CR/CRi & MRD- ➡️ 1y OS 83% 🔹R/R ➡️ 63% CR/CRi 🔹No new sfaety signals ✅ Prospective trials evaluating this combo at @MDAndersonNews #OncoAlert #leusm

0

4

22

Fadi Haddad, MD

@FadiHaddad_MD

3 years

@JoJoBirdHome - High-level patient interaction - The most evolving specialty - Great science - Saving a patient from death is such a rewarding feeling🙌🏻🙌🏻

2

0

21

Fadi Haddad, MD

@FadiHaddad_MD

3 years

Heartbreaking for me 💔 to hear a patient in 🇺🇸 speak about the beauty of #Lebanon 🇱🇧 & asking if we got the criminals behind #August4 blast! While responsibles in my country are careless 😠

1

0

20

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Inspiring @NitinJainMD 💥💥 #Hardwork 📝 after #rounds 😷🧑‍⚕️preparing for #EHA 🇦🇹 with the best fellows in town @jsalwayswins @Dnrbr 🏅 #FridayMotivation #fridaynight #leusm #MedTwitter #socialmedia #endcancer @MDAndersonNews

Nitin Jain

@NitinJainMD

2 years

👉👉With our brilliant superstar Leukemia fellows @FadyyHaddad @Dnrbr @jsalwayswins Late day today working on #EHA abstracts @MDAndersonNews

2

5

47

0

1

21

Fadi Haddad, MD

@FadiHaddad_MD

3 years

Wrapping up the week with a thoughtful surprise from an amazing team🎖️Grateful to have #nurses & #PA dedicated to caring for #Cancer & #leukemia patients. We're all in this together @LeukemiaMDA @MDAndersonNews #leusm #MedTwitter

0

20

Fadi Haddad, MD

@FadiHaddad_MD

2 years

⚠️FLT3 mutation status in acute myeloid leukemia can change between diagnosis & relapse ➡️ Always check for FLT3 mutations at the time of relapse. Full data will be presented at #ASH22 @MusaYilmazMD @GeorgioMedawar @DrHKantarjian @Daver_Leukemia @NicholasShortMD @doctorpemm

Georgio Medawar, MD

@GeorgioMedawar

2 years

Pleasure to have worked with @FadiHaddad_MD and the amazing leukemia team at @MDAndersonNews on this project! In AML, the switch of FLT3 status at relapse is not uncommon. The switch to FLT3m tend to occur more with NRASm #leusm #ASH22 @ASH_hematology

3

4

30

0

5

21

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Curing #Cancer with Love❤️ #HappyValentinesDay from the best Leukemia Team 🥇 @TapKadia 💥 @theABofPharmaC #endcancer #leusm #MedTwitterValentines @MDAndersonNews

Ashley & Brooke Barlow PharmD

@theABofPharmaC

2 years

Platelets are red 🩸, mitoxantrone is blue 🔵 Ibrutinib makes your heart skip a beat ♥️🫀and the excitement of curing leukemia makes ours too! 🤩 Happy Valentines Day from our leukemia team to yours! @MDAndersonNews #leukemia #valentinesdaypoem #oncology #TwitteRx #leusm

3

5

74

0

2

21

Fadi Haddad, MD

@FadiHaddad_MD

3 years

Choose your medical specialty #MedTwitter

7

0

20

Fadi Haddad, MD

@FadiHaddad_MD

2 years

#ASCO22 approaching➡️let's share science among the medical #community on #Twitter 🤓 use #leusm social media hasthag for #leukemia 💥Glad to be part of one the most active groups on social media🌟 @DrHKantarjian @doctorpemm @NitinJainMD @sanamloghavi @NadyaJammal @DrKTakahashi

0

3

20

Fadi Haddad, MD

@FadiHaddad_MD

2 years

✌️Wrapping up yesterday with a highly educational #leukemia session with a special #Focus on new therapies for high risk diseases (MDS/AML) with our #Expert & mentor @Daver_Leukemia from @MDAndersonNews #leusm #ASCO22 @jayastuMD

3

1

20

Fadi Haddad, MD

@FadiHaddad_MD

7 months

Thank you @oncodaily for highlighting our work with @doctorpemm from the 15th International Congress on #MPN #leusm @MeltonMedEd @MDAndersonNews

OncoDaily

@oncodaily

7 months

@FadiHaddad_MD is the Winner of Best Overall Abstract Award at the 15th International Congress on MPNs - @doctorpemm @MDAndersonNews #Cancer #NaveenPemmaraju #OncoDaily #Oncology #MPNs

0

9

1

0

20

Fadi Haddad, MD

@FadiHaddad_MD

3 years

I invite my #ICU & #leukemia colleagues to 👀 this #ASCO21 abstract @ASCO from @LeukemiaMDA Thanks @DanielleHammo20 for coordinating this work🙌🏻 & the exceptional mentorship @TapKadia @DrHKantarjian @garciamanero @doctorpemm more details in thread ⬇️

1

2

20

Fadi Haddad, MD

@FadiHaddad_MD

4 years

Big Success of #FRON2020 in Corona times😷Sharing Science from #Lebanon 🇱🇧 to #France 🇫🇷 Thanks to all participants and the Hematology/Oncology Department of @USJLiban and @hdf_lb for the organization 🏅 Hope to meet next 😁 @GhosnMd @kouriehr @samaharamy @eliasakaram

1

3

20

Fadi Haddad, MD

@FadiHaddad_MD

3 years

مات لانه انسان، وقام لانه الآه🙏🏻 #فصح_مجيد #HappyEaster #Jesusisrisen

0

20

Fadi Haddad, MD

@FadiHaddad_MD

9 months

Dr Jae Park from @MSKCancerCenter : 🔹NGS MRD ➖ is the most important factor predicting for disease relapse after CAR-T infusion 🔹NGS MRD more prognostic compared with B-cell aplasia 🔹Better responses in minimal or no disease burden #SOHO23 @SocietyofHemOnc @AdaptiveBiotech

1

3

19

Fadi Haddad, MD

@FadiHaddad_MD

2 years

⚠️Watch for intracranial hypertension 🤯 as a rare complication of #CML therapy❗Headaches🧠/visual problems👀/brain imaging signs☢️/high CSF pressure⬆️ @DrHKantarjian @GhayasIssa @MDAndersonNews #leusm #MedTwitter #NeuroTwitter #Leukemia #Neurology

Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid...

Published in Leukemia & Lymphoma (Vol. 63, No. 7, 2022)

www.tandfonline.com

0

2

19

Fadi Haddad, MD

@FadiHaddad_MD

2 years

I daily see people losing their battle against disease & realize that we always take life for granted. Just be #grateful & appreciate each moment of your #life #live #love #laugh #hope be thankful 🙌🏻✨

0

1

18

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Happy #4thOfJuly to all my American friends 🇺🇲 A day well spent on board the #USS #Lexington A nice weekend of reflection & positive energy ⚡before resuming work towards our mission of ending Cancer! #endcancer

1

0

19

Fadi Haddad, MD

@FadiHaddad_MD

4 years

Check our paper 📝 on the role of Telemedicine 🖥️ for cancer patients during COVID-19 pandemic😷: between threats and opportunities | Future Oncology @kouriehr @RElkaddoum @RolandEid4

Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities |...

www.futuremedicine.com

1

2

18

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Very nice review!!

Jayastu Senapati

@jayastuMD

2 years

Very happy to have reviewed with Prof @Kadia how to choose the right FLT3 inhibitor in patients with AML. When options increase the right choice can get tougher! @SpringerNature

4

18

105

1

3

18

Fadi Haddad, MD

@FadiHaddad_MD

2 years

Rising star 🌟 @NassifElise from the #sarcoma group @MDAndersonNews discussing neoadjuvant immune checkpoint blockade. Paving the way for future & novel therapies for this rare tumor type! #ESMO2022 @JenWargoMD @CrisyRoland @emilykeungMD @NeetaSomaiahMD

Jennifer Wargo MD

@JenWargoMD

2 years

Excellent talk by ⁦ @NassifElise ⁩ at ESMO on neoadjuvant immune checkpoint blockade in sarcoma with ⁦ @CrisyRoland ⁩ ⁦ @emilykeungMD ⁩ ⁦ @NeetaSomaiahMD ⁩ and others ⁦ @MDAndersonNews ⁩. Important advances for patients shown ⁦ @myESMO ⁩ overall - thx to all